Refractive Surgery Devices Market Size, Share & Forecast Report - 2026 to 2030

The global refractive surgery devices market size is expected to register a significant CAGR of over 7% during the forecast period from 2025 to 2030. The increasing incidence of eye disorders coupled with the growing geriatric population is a prominent factor driving the market growth. Age-related macular degeneration is the prominent cause of vision loss at the age of 65 years and over. According to the United Nations Population Division, 1 in 5 people are likely to be 65 or older by 2035. It is estimated that one in three older people have an eye disorder which is further expected to boost the market.

Moreover, technological advancements such as the advent of wavefront-guided (WFG) surgery and surface ablation technologies are also supporting market growth. Refractive surgery is performed to treat myopia, hyperopia, astigmatism, dry eyes, etc. The increasing incidence of myopia around the world is another prominent factor to drive the market over the forecast period. As per the latest information shared by World Health Organization (WHO), it is estimated that around 5 billion people (~ 52% population of the world) are projected to affect by myopia by 2050.

Market Outlook:

Emerging Trends Shaping the Refractive Surgery Devices Market:

The refractive surgery devices market is witnessing significant growth driven by the increasing prevalence of vision-related disorders such as myopia, hyperopia, and astigmatism across the globe. Technological advancements in laser-based surgeries, including LASIK, SMILE, and PRK, are improving precision, safety, and recovery times, making refractive procedures more appealing to patients. Additionally, rising awareness about eye health and the growing demand for minimally invasive surgical solutions are further fueling market adoption. The integration of femtosecond lasers and wavefront-guided systems has enhanced surgical outcomes, supporting broader acceptance among ophthalmologists and patients alike.

Another key trend in the market is the expansion of refractive surgery applications beyond vision correction to include treatment for presbyopia and keratoconus. Emerging markets, particularly in Asia Pacific and Latin America, are witnessing increased adoption due to improving healthcare infrastructure, rising disposable incomes, and government initiatives supporting eye care programs. Moreover, collaborations between device manufacturers and eye care providers are promoting innovation, enabling the development of customized solutions tailored to patient-specific requirements. This trend toward personalized, high-precision ophthalmic care is expected to drive sustained growth in the global refractive surgery devices market.

Refractive Surgery Devices Market Key Drivers:

• Increasing prevalence of refractive errors: Refractive errors, such as myopia (nearsightedness), hyperopia (farsightedness), and astigmatism, are widespread eye conditions globally. The rising prevalence of these disorders has led to an increased demand for refractive surgery procedures, thus driving the market for refractive surgery devices.
• Technological advancements: Advancements in technology have significantly improved the safety, precision, and effectiveness of refractive surgery procedures. Innovative devices, such as femtosecond lasers, excimer lasers, and diagnostic devices, have revolutionized the field of refractive surgery, attracting more patients and driving market growth.
• Growing patient preference for minimally invasive procedures: Refractive surgery offers a minimally invasive alternative to correct vision problems without the need for glasses or contact lenses. With the desire for improved quality of life and convenience, patients are increasingly opting for refractive surgery procedures. This preference for minimally invasive treatments is propelling the demand for refractive surgery devices.
• Increasing disposable income and healthcare spending: Rising disposable income levels and increased healthcare expenditure in many regions have made refractive surgery more accessible to a larger population. As more individuals can afford refractive procedures, the demand for refractive surgery devices is growing.
• Aging population: The global population is aging, and with age comes an increased risk of developing age-related vision problems, such as presbyopia. Refractive surgery devices, such as intraocular lenses (IOLs) and phakic IOLs, are commonly used to address presbyopia and other age-related vision issues. The expanding elderly population is thus contributing to the growth of the refractive surgery devices market.
• Medical tourism: Medical tourism has gained popularity, with individuals traveling to different countries to seek affordable and high-quality medical treatments, including refractive surgery. Countries offering advanced refractive surgery procedures at competitive prices attract international patients, thereby boosting the demand for refractive surgery devices.
• Supportive regulatory environment: Governments and regulatory bodies in various countries have taken initiatives to promote and regulate refractive surgery. Favorable regulations and policies that ensure patient safety and quality standards create a conducive environment for the market’s growth.

Future Opportunities Shaping the Refractive Surgery Devices Market’s Evolution:

The refractive surgery devices market presents substantial opportunities driven by the rising global prevalence of vision disorders and increasing demand for minimally invasive eye care procedures. With more people affected by myopia, hyperopia, and astigmatism—especially among younger populations—there is a growing need for safe, effective, and quick vision correction solutions. Advances in laser technology, such as femtosecond lasers and SMILE procedures, provide opportunities for device manufacturers to offer enhanced precision and faster recovery times, attracting more patients to undergo refractive surgery.

Another key opportunity lies in emerging markets where improving healthcare infrastructure, growing disposable incomes, and government initiatives to enhance eye care accessibility are boosting adoption. Expanding the scope of refractive surgery to treat presbyopia, keratoconus, and other complex eye conditions opens new avenues for growth. Additionally, partnerships between ophthalmic device manufacturers and hospitals or clinics can facilitate the introduction of innovative, patient-specific solutions, creating a competitive edge and driving market expansion in both developed and developing regions.

Market Segments Insights:

The global refractive surgery device market is bifurcated into product, application, end-use, and geography. On the basis of product, the market is further segmented into lasers, microkeratome, aberrometers, and others. The laser segment dominated the global market in 2024 and is estimated to hold the largest market share of over one-third of the market. The segment growth is attributed to the increasing adoption of refractive surgeries due to its success rate over contact lenses and eyeglasses. On the other hand, the microkeratome segment is expected to grow at a significant growth rate over the forecast period due to the increasing incidence of eye disorder and the growing geriatric population.

On the basis of application, the market is segmented into Myopia, Hyperopia, Astigmatism, and others. The myopia segment dominated the global refractive surgery devices market in 2024 and accounted to hold a major market share of over one-fourth percent of the market by revenue. The increasing incidence of myopia coupled with the risk of vision loss is one of the prominent factor to drive the segment growth. According to WHO, approximately 52% of world’s population may be affected by myopia by 2050. In contrast, the astigmatism segment is expected to grow at a fast growth rate over the forecast period.

The refractive surgery devices comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Refractive Surgery Devices Market Segmentation:

By Product:

• Lasers
• Microkeratome
• Aberrometers
• Others

By Application:

• Myopia
• Hyperopia
• Astigmatism
• Presbyopia
• Dry Eyes

By End-Use:

• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage: North America Leads the Refractive Surgery Devices Market

Geographically, North America dominated the global refractive surgery devices market in 2024 and accounted to hold the largest revenue share of around one-third share of the market. The increasing prevalence of eye-related disorder and growing geriatric population are some factors contributed the market growth in the region. Furthermore, the availability of effective reimbursement policies coupled with the presence of some major payers is expected to boost the market in North America. On the other hand, the Asia Pacific is estimated to grow at the fastest growth rate over the forecast period.

Competition Assessment:

Some of the major players operating in the global refractive surgery devices market are Johnson & Johnson Services, Inc., ZEISS International, Novartis AG, Nidek Co., Ltd., and SCHWIND eye-tech-solutions GmbH & Co. KG. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Johnson & Johnson Services, Inc.
• ZEISS International
• Novartis AG
• Nidek Co., Ltd.
• SCHWIND eye-tech-solutions GmbH & Co. KG
• Ellex Medical Lasers Limited.
• Topcon Corporation
• Essilor
• Avedro, Inc.
• Bausch Health Companies Inc.

Key Questions Answered by Refractive Surgery Devices Market Report

• Global refractive surgery devices market forecasts from 2021-2027
• Regional refractive surgery devices market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
• Refractive surgery devices submarket forecasts from 2021-2027 covering the market by product, by application, by end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the refractive surgery devices market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level refractive surgery devices markets from 2021-2027
• Competitive Landscape and market positioning of top 10 players operating in the refractive surgery devices market